Search
Now showing items 1-4 of 4
Anaesthetic management of people with multiple sclerosis.
(2023-10-11)
There is a lack of published guidelines on the management of patients with multiple sclerosis (MS) undergoing procedures that require anaesthesia and respective advice is largely based on retrospective studies or case ...
Organic solvents and Multiple Sclerosis: the doubled risk dilemma.
(2023-09-29)
BACKGROUND: Compensation for industrial disease in the UK may be obtained in two ways. A State scheme includes a list of accepted associations between occupations and diseases with evidence of a causative association. ...
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis.
(2023)
BACKGROUND: Cladribine is an effective immunotherapy for people with multiple sclerosis (pwMS). Whilst most pwMS do not require re-treatment following standard dosing (two treatment courses), disease activity re-emerges ...